questionsmedicales.fr
Hémopathies et maladies lymphatiques
Hémopathies
Maladies de la moelle osseuse
Maladies de la moelle osseuse : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Maladies de la moelle osseuse : Questions médicales les plus fréquentes",
"headline": "Maladies de la moelle osseuse : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Maladies de la moelle osseuse : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-15",
"dateModified": "2025-04-10",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Maladies de la moelle osseuse"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hémopathies",
"url": "https://questionsmedicales.fr/mesh/D006402",
"about": {
"@type": "MedicalCondition",
"name": "Hémopathies",
"code": {
"@type": "MedicalCode",
"code": "D006402",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Aplasies médullaires",
"alternateName": "Bone Marrow Failure Disorders",
"url": "https://questionsmedicales.fr/mesh/D000080983",
"about": {
"@type": "MedicalCondition",
"name": "Aplasies médullaires",
"code": {
"@type": "MedicalCode",
"code": "D000080983",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.223"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anémie aplasique",
"alternateName": "Anemia, Aplastic",
"url": "https://questionsmedicales.fr/mesh/D000741",
"about": {
"@type": "MedicalCondition",
"name": "Anémie aplasique",
"code": {
"@type": "MedicalCode",
"code": "D000741",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.223.250"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Maladies myélodysplasiques-myéloprolifératives",
"alternateName": "Myelodysplastic-Myeloproliferative Diseases",
"url": "https://questionsmedicales.fr/mesh/D054437",
"about": {
"@type": "MedicalCondition",
"name": "Maladies myélodysplasiques-myéloprolifératives",
"code": {
"@type": "MedicalCode",
"code": "D054437",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.615"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Leucémie myélomonocytaire juvénile",
"alternateName": "Leukemia, Myelomonocytic, Juvenile",
"url": "https://questionsmedicales.fr/mesh/D054429",
"about": {
"@type": "MedicalCondition",
"name": "Leucémie myélomonocytaire juvénile",
"code": {
"@type": "MedicalCode",
"code": "D054429",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.615.520"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Syndromes myélodysplasiques",
"alternateName": "Myelodysplastic Syndromes",
"url": "https://questionsmedicales.fr/mesh/D009190",
"about": {
"@type": "MedicalCondition",
"name": "Syndromes myélodysplasiques",
"code": {
"@type": "MedicalCode",
"code": "D009190",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.625"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anémie réfractaire",
"alternateName": "Anemia, Refractory",
"url": "https://questionsmedicales.fr/mesh/D000753",
"about": {
"@type": "MedicalCondition",
"name": "Anémie réfractaire",
"code": {
"@type": "MedicalCode",
"code": "D000753",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.625.062"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anémie réfractaire avec excès de blastes",
"alternateName": "Anemia, Refractory, with Excess of Blasts",
"url": "https://questionsmedicales.fr/mesh/D000754",
"about": {
"@type": "MedicalCondition",
"name": "Anémie réfractaire avec excès de blastes",
"code": {
"@type": "MedicalCode",
"code": "D000754",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.625.062.080"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Anémie réfractaire avec excès de blastes",
"alternateName": "Anemia, Refractory, with Excess of Blasts",
"url": "https://questionsmedicales.fr/mesh/D000754",
"about": {
"@type": "MedicalCondition",
"name": "Anémie réfractaire avec excès de blastes",
"code": {
"@type": "MedicalCode",
"code": "D000754",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.625.062.080"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anémie sidéroblastique",
"alternateName": "Anemia, Sideroblastic",
"url": "https://questionsmedicales.fr/mesh/D000756",
"about": {
"@type": "MedicalCondition",
"name": "Anémie sidéroblastique",
"code": {
"@type": "MedicalCode",
"code": "D000756",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.625.070"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hémoglobinurie paroxystique",
"alternateName": "Hemoglobinuria, Paroxysmal",
"url": "https://questionsmedicales.fr/mesh/D006457",
"about": {
"@type": "MedicalCondition",
"name": "Hémoglobinurie paroxystique",
"code": {
"@type": "MedicalCode",
"code": "D006457",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.625.460"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Syndromes myéloprolifératifs",
"alternateName": "Myeloproliferative Disorders",
"url": "https://questionsmedicales.fr/mesh/D009196",
"about": {
"@type": "MedicalCondition",
"name": "Syndromes myéloprolifératifs",
"code": {
"@type": "MedicalCode",
"code": "D009196",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.636"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anémie myélophtisique",
"alternateName": "Anemia, Myelophthisic",
"url": "https://questionsmedicales.fr/mesh/D000750",
"about": {
"@type": "MedicalCondition",
"name": "Anémie myélophtisique",
"code": {
"@type": "MedicalCode",
"code": "D000750",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.636.085"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Leucémie érythroblastique aigüe",
"alternateName": "Leukemia, Erythroblastic, Acute",
"url": "https://questionsmedicales.fr/mesh/D004915",
"about": {
"@type": "MedicalCondition",
"name": "Leucémie érythroblastique aigüe",
"code": {
"@type": "MedicalCode",
"code": "D004915",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.636.276"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Myélofibrose primitive",
"alternateName": "Primary Myelofibrosis",
"url": "https://questionsmedicales.fr/mesh/D055728",
"about": {
"@type": "MedicalCondition",
"name": "Myélofibrose primitive",
"code": {
"@type": "MedicalCode",
"code": "D055728",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.636.765"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thrombocytose",
"alternateName": "Thrombocytosis",
"url": "https://questionsmedicales.fr/mesh/D013922",
"about": {
"@type": "MedicalCondition",
"name": "Thrombocytose",
"code": {
"@type": "MedicalCode",
"code": "D013922",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.636.860"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Maladies de la moelle osseuse",
"alternateName": "Bone Marrow Diseases",
"code": {
"@type": "MedicalCode",
"code": "D001855",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sebastian Berg",
"url": "https://questionsmedicales.fr/author/Sebastian%20Berg",
"affiliation": {
"@type": "Organization",
"name": "Division of Pediatric Radiology, Department of Radiology, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany."
}
},
{
"@type": "Person",
"name": "Charlotte Niemeyer",
"url": "https://questionsmedicales.fr/author/Charlotte%20Niemeyer",
"affiliation": {
"@type": "Organization",
"name": "Division of Pediatric Hematology and Oncology, Department of Pediatric and Adolescent Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany."
}
},
{
"@type": "Person",
"name": "Ioannis Mitroulis",
"url": "https://questionsmedicales.fr/author/Ioannis%20Mitroulis",
"affiliation": {
"@type": "Organization",
"name": "Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Germany (I.M., T.C.)."
}
},
{
"@type": "Person",
"name": "George Hajishengallis",
"url": "https://questionsmedicales.fr/author/George%20Hajishengallis",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Innate Immunity and Inflammation, Department of Basic and Translational Sciences, Penn Dental Medicine, University of Pennsylvania, Philadelphia (G.H.)."
}
},
{
"@type": "Person",
"name": "Triantafyllos Chavakis",
"url": "https://questionsmedicales.fr/author/Triantafyllos%20Chavakis",
"affiliation": {
"@type": "Organization",
"name": "Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Germany (I.M., T.C.)."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "PyFREC 2.0: Software for excitation energy transfer modeling.",
"datePublished": "2022-05-24",
"url": "https://questionsmedicales.fr/article/35608241",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jcc.26930"
}
},
{
"@type": "ScholarlyArticle",
"name": "CrisprVi: a software for visualizing and analyzing CRISPR sequences of prokaryotes.",
"datePublished": "2022-05-11",
"url": "https://questionsmedicales.fr/article/35610585",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12859-022-04716-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Inter-software and inter-scan variability in measurement of epicardial adipose tissue: a three-way comparison of a research-specific, a freeware and a coronary application software platform.",
"datePublished": "2023-06-27",
"url": "https://questionsmedicales.fr/article/37369831",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00330-023-09878-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Interactive hygiene training using free open source software.",
"datePublished": "2024-10-30",
"url": "https://questionsmedicales.fr/article/39477239",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjoq-2024-002861"
}
},
{
"@type": "ScholarlyArticle",
"name": "Virtual bracket removal: a comparative assessment of different software packages.",
"datePublished": "2024-07-10",
"url": "https://questionsmedicales.fr/article/38982396",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12903-024-04522-0"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Hémopathies et maladies lymphatiques",
"item": "https://questionsmedicales.fr/mesh/D006425"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hémopathies",
"item": "https://questionsmedicales.fr/mesh/D006402"
},
{
"@type": "ListItem",
"position": 4,
"name": "Maladies de la moelle osseuse",
"item": "https://questionsmedicales.fr/mesh/D001855"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Maladies de la moelle osseuse - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Maladies de la moelle osseuse",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Maladies de la moelle osseuse",
"description": "Comment diagnostiquer une maladie de la moelle osseuse ?\nQuels tests sont utilisés pour évaluer la moelle osseuse ?\nQuels signes indiquent une maladie de la moelle osseuse ?\nQuelle imagerie est utilisée pour la moelle osseuse ?\nLes tests sanguins peuvent-ils détecter des maladies de la moelle ?",
"url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Software&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Maladies de la moelle osseuse",
"description": "Quels sont les symptômes courants des maladies de la moelle osseuse ?\nComment la moelle osseuse affecte-t-elle le système immunitaire ?\nLes maladies de la moelle osseuse causent-elles des saignements ?\nPeut-on avoir des douleurs osseuses avec ces maladies ?\nLes symptômes varient-ils selon le type de maladie ?",
"url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Software&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Maladies de la moelle osseuse",
"description": "Peut-on prévenir les maladies de la moelle osseuse ?\nQuels facteurs de risque sont évitables ?\nL'alimentation joue-t-elle un rôle dans la prévention ?\nLe tabagisme influence-t-il les maladies de la moelle ?\nLes examens réguliers aident-ils à la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Software&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Maladies de la moelle osseuse",
"description": "Quels traitements sont disponibles pour les maladies de la moelle osseuse ?\nLa greffe de moelle osseuse est-elle efficace ?\nQuels médicaments sont utilisés pour traiter ces maladies ?\nLa radiothérapie est-elle une option de traitement ?\nLes traitements sont-ils personnalisés ?",
"url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Software&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Maladies de la moelle osseuse",
"description": "Quelles complications peuvent survenir avec ces maladies ?\nLes maladies de la moelle osseuse augmentent-elles le risque de cancer ?\nComment les infections sont-elles liées à ces maladies ?\nLes saignements peuvent-ils être graves ?\nQuelles sont les conséquences d'une insuffisance médullaire ?",
"url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Software&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Maladies de la moelle osseuse",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque de maladies de la moelle ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nLe mode de vie peut-il affecter le risque ?\nLes infections virales sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Software&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une maladie de la moelle osseuse ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par des analyses sanguines, biopsies et examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la moelle osseuse ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'aspiration de moelle osseuse et des tests génétiques."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une maladie de la moelle osseuse ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes incluent fatigue, infections fréquentes et saignements anormaux."
}
},
{
"@type": "Question",
"name": "Quelle imagerie est utilisée pour la moelle osseuse ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM et la tomodensitométrie sont souvent utilisées pour visualiser la moelle."
}
},
{
"@type": "Question",
"name": "Les tests sanguins peuvent-ils détecter des maladies de la moelle ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests sanguins peuvent révéler des anomalies dans les cellules sanguines."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des maladies de la moelle osseuse ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, fièvre, ecchymoses et douleurs osseuses."
}
},
{
"@type": "Question",
"name": "Comment la moelle osseuse affecte-t-elle le système immunitaire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une moelle osseuse malade peut réduire la production de globules blancs, affaiblissant l'immunité."
}
},
{
"@type": "Question",
"name": "Les maladies de la moelle osseuse causent-elles des saignements ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des saignements excessifs en raison d'une faible production de plaquettes."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des douleurs osseuses avec ces maladies ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs osseuses peuvent survenir en raison de l'infiltration de cellules anormales."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de maladie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon le type de maladie de la moelle osseuse."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les maladies de la moelle osseuse ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies sont héréditaires, mais un mode de vie sain peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont évitables ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition à des produits chimiques toxiques peut réduire le risque."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la santé de la moelle osseuse et du sang."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il les maladies de la moelle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque pour plusieurs maladies hématologiques."
}
},
{
"@type": "Question",
"name": "Les examens réguliers aident-ils à la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter précocement des anomalies."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les maladies de la moelle osseuse ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent chimiothérapie, radiothérapie et greffe de moelle osseuse."
}
},
{
"@type": "Question",
"name": "La greffe de moelle osseuse est-elle efficace ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être curative pour certaines maladies, mais comporte des risques."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour traiter ces maladies ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les agents immunosuppresseurs et les facteurs de croissance sont utilisés."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle une option de traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la radiothérapie peut être utilisée pour traiter certaines formes de cancer de la moelle."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont souvent adaptés en fonction du type et de la gravité de la maladie."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec ces maladies ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent infections, saignements et insuffisance médullaire."
}
},
{
"@type": "Question",
"name": "Les maladies de la moelle osseuse augmentent-elles le risque de cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies de la moelle osseuse peuvent augmenter le risque de cancers secondaires."
}
},
{
"@type": "Question",
"name": "Comment les infections sont-elles liées à ces maladies ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une moelle osseuse défaillante peut entraîner une immunodéficience, augmentant le risque d'infections."
}
},
{
"@type": "Question",
"name": "Les saignements peuvent-ils être graves ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des saignements graves peuvent survenir en raison d'une faible production de plaquettes."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une insuffisance médullaire ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'insuffisance médullaire peut entraîner une anémie sévère, des infections et des hémorragies."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'exposition à des radiations, des produits chimiques et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de maladies de la moelle ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout après 60 ans."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent augmenter le risque de troubles de la moelle osseuse."
}
},
{
"@type": "Question",
"name": "Le mode de vie peut-il affecter le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes comme le tabagisme et une mauvaise alimentation peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les infections virales sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales, comme le VIH, peuvent augmenter le risque de maladies de la moelle."
}
}
]
}
]
}
└─
Aplasies médullaires
Bone Marrow Failure Disorders
D000080983
-
C15.378.190.223
└─
Maladies myélodysplasiques-myéloprolifératives
Myelodysplastic-Myeloproliferative Diseases
D054437
-
C15.378.190.615
└─
Syndromes myélodysplasiques
Myelodysplastic Syndromes
D009190
-
C15.378.190.625
└─
Syndromes myéloprolifératifs
Myeloproliferative Disorders
D009196
-
C15.378.190.636
└─└─
Anémie aplasique
Anemia, Aplastic
D000741
-
C15.378.190.223.250
└─└─
Leucémie myélomonocytaire juvénile
Leukemia, Myelomonocytic, Juvenile
D054429
-
C15.378.190.615.520
└─└─
Anémie réfractaire
Anemia, Refractory
D000753
-
C15.378.190.625.062
└─└─
Anémie sidéroblastique
Anemia, Sideroblastic
D000756
-
C15.378.190.625.070
└─└─
Hémoglobinurie paroxystique
Hemoglobinuria, Paroxysmal
D006457
-
C15.378.190.625.460
└─└─
Anémie myélophtisique
Anemia, Myelophthisic
D000750
-
C15.378.190.636.085
└─└─
Leucémie érythroblastique aigüe
Leukemia, Erythroblastic, Acute
D004915
-
C15.378.190.636.276
└─└─
Myélofibrose primitive
Primary Myelofibrosis
D055728
-
C15.378.190.636.765
└─└─
Thrombocytose
Thrombocytosis
D013922
-
C15.378.190.636.860
└─└─└─
Anémie réfractaire avec excès de blastes
Anemia, Refractory, with Excess of Blasts
D000754
-
C15.378.190.625.062.080
Excitation energy transfer is a ubiquitous process of fundamental importance for understanding natural phenomena, such as photosynthesis, as well as advancing technologies ranging from photovoltaics t...
Clustered regularly interspaced short palindromic repeats (CRISPR) and their spacers are important components of prokaryotic CRISPR-Cas systems. In order to analyze the CRISPR loci of multiple genomes...
CrisprVi is a Python package consisting of a graphic user interface (GUI) for visualization, a module for commands parsing and data transmission, local SQLite and BLAST databases for data storage and ...
CrisprVi is a convenient tool for visualizing and analyzing the CRISPR sequences and it would be helpful for users to inspect novel CRISPR-Cas systems of prokaryotes....
Epicardial adipose tissue (EAT) is a proposed marker of cardiovascular risk; however, clinical application may be limited by variability in post-processing software platforms. We assessed inter-vendor...
Seventy-six consecutive patients undergoing simultaneous CE and NCT had complete volumetric EAT measurement. Between-software, within-software NCT vs. CE, and inter- and intra-observer agreement were ...
Mean EATv (freeware 53 ± 31 mL vs. research 93 ± 43 mL vs. coronary 157 ± 64 mL) and attenuation (freeware - 72 ± 25 HU vs. research - 75 ± 3 HU vs. coronary - 61 ± 10 HU) were significantly different...
There are significant inter-vendor differences in EAT assessment. Our study suggests that research-specific software has better agreement and reproducibility compared to freeware or coronary software ...
• There are significant differences between EAT volume and attenuation values between software platforms, regardless of scan type. • Non-contrast scans routinely have higher mean EAT volume and attenu...
Regular hygiene trainings are an important way to refresh and improve knowledge about hygiene measures and the prevention of healthcare-associated infections. We aimed to develop an e-learning course ...
We developed an interactive hygiene training for HCWs of a tertiary care hospital using different content types of the HTML-5 package (H5P) plugin embedded into a Moodle-based learning management syst...
We present various suitable topics for online hygiene trainings as well as their implementation in an e-learning course. Examples include content on hand hygiene indications and techniques, informatio...
Currently available commercial and non-commercial hygiene trainings present a number of specific advantages but also drawbacks. The presented approach combines the advantages of both approaches. The m...
H5P course presentations are a low-threshold, cost-effective way to implement digital hygiene trainings in a wide variety of clinical settings....
High precision intra-oral scans, coupled with advanced software, enable virtual bracket removal (VBR) from digital models. VBR allows the delivery of retainers and clear aligners promptly following de...
Maxillary scans of 20 participants starting orthodontic treatment were selected for inclusion in the study, who exhibited mild to moderate crowding and required bonding of brackets on the labial surfa...
There was a significant difference among the 3Shape, Meshmixer, and EasyRx software in tooth surface change following VBR. Specifically, EasyRx exhibited lower levels of accuracy compared to the other...
3Shape and Meshmixer manual VBR software were found to be more accurate than EasyRx automated software, however, the differences were minimal and clinically insignificant....
How to cite this article: Abhishek G. The Evolving Landscape of Shade Matching: From Softwares to Mobile Apps. J Contemp Dent Pract 2024;25(5):403-404. Keywords: Digital shade guide, Mobile shade matc...
Public health surveillance traditionally occurs at a health facility; however, there is growing concern that this provides only partial and untimely health information. Community-based surveillance (C...
We conducted a scoping review of academic literature and supplemental resources and conducted qualitative interviews with stakeholders working with digital community health and surveillance tools....
All of the tools reviewed have features necessary to support the reporting process of CBS; only 3 (CommCare, Community Health Toolkit, and DHIS2 Tracker) provided all 10 attributes included in the map...
The findings demonstrate that several software tools are available to facilitate public health surveillance at the community level. In the future, emphasis should be put on contextualizing these tools...
Several raw-data processing software for accelerometer-measured physical activity (PA) exist, but whether results agree has not been assessed. We examined the agreement between three different softwar...
Computer-assisted arthroplasty supports the surgeons in planning, simulating, and performing the replacement procedure, using robotic or navigation technologies. However, the safety of the technology ...
The Medical Device Recalls database was investigated about software-related recalls in computer-assisted hip and knee arthroplasty surgery, between 2017 and 2022. The incidence of the software-related...
Eighteen recall numbers could be identified (1.6%), corresponding to 11 recall events. A total of 4634 units were involved. The FDA determined root causes were: software design (66.6%), design change ...
Software-related recalls in computer-assisted hip and knee arthroplasty were quite uncommon among all the recalls, deemed non-life threatening and usually due to software design errors. The main actio...
Genotyping and sequencing technologies produce increasingly large numbers of genetic markers with potentially high rates of missing or erroneous data. Therefore, the construction of linkage maps is mo...
In this context, the SeSAM software allows automatic genetic map construction using seriation and placement approaches, to produce (1) a high-robustness framework map which includes as many markers as...
SeSAM is a fully automatic linkage mapping software designed to (1) produce a framework map as robust as desired by optimizing the selection of a subset of markers, and (2) produce a high-density map ...